Zapping heart veins: new device trial aims to control irregular heartbeat
NCT ID NCT05572047
Summary
This study is testing the safety and effectiveness of a new medical device called the Arga Medtech CSE Ablation System. It uses electrical pulses to create scar tissue that blocks the faulty electrical signals causing atrial fibrillation (AFib). The study involves 25 patients whose AFib wasn't controlled by medication, and it checks if the treatment successfully isolates the heart's pulmonary veins and reduces AFib episodes over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Israeli-Georgian Medical Research Clinic Helthycore Ltd
Tbilisi, 0112, Georgia
-
KBC Zagreb
Zagreb, HR-10 000, Croatia
-
University Hospital of Split
Split, 21 000, Croatia
Conditions
Explore the condition pages connected to this study.